NGFR and melanoma: On the basis of its molecular program, the de-differentiation persistent state is potentially related to the NGFR/CD271hi state reported by Landsberg et al. [54] as a resistance mechanism to adaptive T-cell therapy, and to the NGFR/CD271hi state of melanoma stem cells [52, 72], which, however, is still debated [73].